Australia's largest stock trading and investment forum Australia's #1 stock forum

REF

Click for more information

0.00%

0.3¢ reverse corp limited

Ann: Dividend/Distribution - REF, page-30

First 30 Last

Share
Profile

Follow
Patient

2,443 Posts.

213

04/09/18

05:35

Post #: 35389970
Share

Originally posted by MarsC ↑

Ok, after reading the small notes properly, and re-doing my numbers, here's what I get:

In FY16 the contact lense business was generating annual revenues of about $1.5 m. In the H1 period of FY17, annual revenues of about $0.87 m (^) were acquired (acquisition of Net Contacts). In the H1 period of FY18, annual revenues of $1.2 m (+) were acquired (acquisition of WebContacts and YourContacts). So pro-forma, and absent any organic growth, the business should now be generating annual revenues of $1.5m + $0.88m + $1.2m = $3.58m.

Fast forward to the H2 FY18 period, and annual revenue (in online contacts retailing) was reported at $4.5m. The reported H1 FY18 revenue was $2.0m, meaning H2 FY18 revenues were $2.5m, which crudely annualises to 2 x $2.5m = $5.0m.

Expand

That's a whole lot of work for someone bordering on sloth Thanks

REF Price at posting: 9.2¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

STK

Strickland Metals jumps on mammoth gold-copper-silver hit over 300m width at Serbian Rogozna Project

FL1

First Lithium hits high-grade mineralisation in all holes of diamond program in Mali

The Rising Tide: How institutional adoption is shaping the future of crypto

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

CU6

US FDA awards Clarity Pharma's novel prostate cancer PET scan imaging compound fast track status

There are more pages in this discussion • 17 more messages in this thread...

First 30 Last

Add REF (ASX) to my watchlist

SPONSORED BY